Danaher is making good use of mergers and acquisitions once again. But we could have had enough
Danaher's days in the portfolio may be numbered. We were once again disappointed after Danaher's latest acquisition plan failed to…
ISHARES US Medical Device ETF
Strategas sees healthcare outperforming in 2025
The healthcare sector is poised to see a rebound and lead the market this year, according to analysts at Strategas,…